TANVEX BIOPHARMA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.55 TWD | +1.28% |
|
-2.57% | -33.10% |
| 03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-06 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 46.00 | 57.50 | 61.50 |
| Spread/Res. | -5.33% | -24.26% | -29.19% |
| Spread/Supp. | +1.28% | +1.28% | +1.28% |
| Support | 43.00 | 43.00 | 43.00 |
- Stock Market
- Equities
- 6541 Stock
- Charts Tanvex BioPharma, Inc.
